The global shift towards proactive health management and personalized nutrition is accelerating, with consumers seeking convenient, science-backed solutions. Regulatory frameworks for functional foods are evolving, creating clear pathways for innovative products like this functional rice. This technology capitalizes on the growing demand for dietary interventions that integrate seamlessly into daily life, offering a significant competitive edge in the rapidly expanding health and wellness market, particularly for cardiovascular health.
Establishes a unique market position with only 3 prior art references cited by examiners
Enables convenient blood pressure management by integrating health benefits into a daily staple
Leverages high scientific credibility from national research institution backing
This patent protects genetically modified rice expressing novokinin peptides, along with derived food compositions, propagating material, seeds, and cells. It establishes a broad scope with 9 claims, demonstrating strong technical superiority and low invalidation risk, having successfully navigated examination with minimal prior art.
This patent primarily covers novokinin-expressing GM rice. White space exists in developing other functional peptide-expressing crops or exploring novel delivery mechanisms for cardiovascular health benefits beyond staple foods.
Blood pressure care is a key growth area in the domestic functional food market. Assuming this technology captures 6% of the existing blood pressure-lowering supplement market (approximately ~$13.5B (AI est.)), it could generate ~$80M/year (AI est.) in new sales. The ease of health management through daily staple rice is expected to drive high consumer acceptance and accelerate market expansion.
X: Ease of Integration into Daily Diet
Y: Functionality Based on Scientific Evidence